FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to a metachsalon dosage form. Dosage dosage form comprises 300 or 600 mg of metaxalone for relieving discomfort associated with acute painful musculoskeological conditions, wherein the dispensed dosage form contains a surfactant and at least one of mannitol, sorbitol, isomalt, xylitol, maltitol, lactitol, erythritol, arabitol, ribitol, glucose, fructose, mannose, galactose, anhydrous lactose, lactose monohydrate, sucrose, maltose, trehalose, maltodextrins, dextrin and inuline, the average size of metaxalone particles is between 50 and 900 nm, wherein rate of dissolving metaksalone, determined using tester using 1000 ml of 0.01 n. HCl at pH = 2 at 37 °C and a vane device for dissolving type 2 at a rotation speed of 100 rpm, such that at least 80 % is dissolved for 60 minutes.
EFFECT: relief of acute painful musculoskeological pathological conditions.
46 cl, 3 ex, 3 dwg, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
LOW-DOSE PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN FOR ORAL ADMINISTRATION | 2015 |
|
RU2707753C2 |
PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN | 2008 |
|
RU2484816C2 |
COMPOSITIONS CONTAINING 15-HEPE, AND METHODS OF USING THEM | 2016 |
|
RU2737089C2 |
GASTRO-RESISTANT DOSAGE FORMS FOR ORAL ADMINISTRATION WITH CONTROLLED RELEASE | 2018 |
|
RU2812901C2 |
CRF1 RECEPTOR ANTAGONIST, PHARMACEUTICAL FORMULATIONS AND SOLID FORMS FOR TREATING CONGENITAL ADRENAL HYPERPLASIA | 2019 |
|
RU2824490C2 |
TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS | 2009 |
|
RU2574006C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HELICOBACTER PYLORI | 2014 |
|
RU2671400C2 |
COMPOSITIONS IN THE FORM OF A SPRAY FOR ORAL ADMINISTRATION AND METHODS OF THE SILDENAFIL ADMINISTRATION | 2012 |
|
RU2611403C1 |
SOLID DOSAGE FORMS OF ONDANSETRON WITH PROLONGED RELEASE FOR TREATING SYMPTOMS OF NAUSEA, VOMITING AND DIARRHEA | 2015 |
|
RU2706708C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DGLA, AND USE THEREOF | 2015 |
|
RU2714323C2 |
Authors
Dates
2019-04-16—Published
2014-07-22—Filed